$IMGN
Immunogen, Inc.
- NASDAQ
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
PRICE
$3.8 ▲0.264%
Extented Hours
VOLUME
2,218,491
DAY RANGE
3.66 - 3.83
52 WEEK
3.1 - 6.63
Join Discuss about IMGN with like-minded investors
@soheil.n #StockTraders.NET
recentlyIU Watchlist: Main Watches: $CFVI lets see it off open I could easily see this puking back under $10 in a hurry after unloading huge today. That said - I don't want to get biased let's see what we're doing pre market weak open red/green trappy? Gap .. failed follow through - the usual. More on broadcast. $ARDX big squeezer - impressive come back not sure why I didn't load the boat but nice idea today. I'd love to see $2.20-2.50 + blow off and fade in a perfect world. If it fades off tomorrow and traps on green/red move then I'd entertained a long. $LCID solid trade today looking to trade it reactively tomorrow again or join trend. $F good levels today VWAP was the key each time it kissed it bounced. Higher better and back side is ideal. Failed Follow Through: $BFRI nice one today - ideally get a morning shove then use today's levels for exhaustion points. $PPSI nice fade today - morning shove .20-.30 and looking for failed follow through Continuation: $PTPI has the POTENTIAL of going - but so far was WAY thicker than I would have imagined sometimes though these things unwind and then come back further than people think quickly they short and end up in a bad spot -- we'll see I was impressed with rebound today but keeping a watch in case a cover comes in back over pricing. $IMGN so far so good nice trade plan last few days. $ABUS nice gap this AM nice levels for the long and also great reminder on the exits $5.20 -- I always like to remind folks to lock in when it starts to get 50/50 b/c I know people have a hard time shifting from one idea to the need to adapt -- and letting go your original thought if the trend doesn't agree.
57 Replies 15 👍 10 🔥
@maletone #StockTraders.NET
recentlywatchlist for tomorrow: $ARDX, $CFVI, $TOMZ, $IMGN
72 Replies 7 👍 13 🔥
@soheil.n #StockTraders.NET
recentlywatchlist: main: $IMGN looking for 7.2-.4 reject $ABUS: will long if 4.8-5 holds...then looking for ss around 6 secondary: $OMER - push into previous supply zone $CFVI - no previous OH...may look for a long if it flushes or ss if it goes para
69 Replies 15 👍 7 🔥
@soheil.n #StockTraders.NET
recently$IMGN - MOFO ...i knew it would settle back and got emotional cause i got in early and fucked myself up
94 Replies 12 👍 15 🔥
@TraderXx #StockTraders.NET
recentlyam still holding my starter at 7.15 > @maletone said: cutting $IMGn nflat
143 Replies 11 👍 9 🔥
@soheil.n #StockTraders.NET
recentlyIU Watchlist: Main Watches: $CPIX had a lil push AHs didn't expect it to catch and didn't but hopefully some gap and continuation before more action to fade tomorrow. Nice trade on this one today. Great discussion about it and cover spots. Well done. $F great job today - higher better and looking for the same trade I spelled out on Sunday video. Still think we need that gut check I mentioned to $17.50s $ADGI sick one today - morning shove and looking for sub $30 Failed Follow Through: $ARQQ $IMGN $PPSI Continuation: $IBRX nice trend join today looking to let it work as long as it can. $ARDX held some over nice alert of the PT upgrade. Sold half held rest will bail if no follow through. $GRTS nice idea today sold 2/3s - kept rest will bail on rest if it stops going up hit mid $15s AHs $VRPX nibbled today - watching dips for possible break out continuation $FCUV steady grind from bigger picture idea. $AGIL looking for trend join
138 Replies 6 👍 15 🔥
@maletone #StockTraders.NET
recently$IMGN has a webcast at 8 am https://investor.immunogen.com/
136 Replies 11 👍 11 🔥
Key Metrics
Market Cap
856.71 M
Beta
1.37
Avg. Volume
3.67 M
Shares Outstanding
226.05 M
Yield
0%
Public Float
0
Next Earnings Date
2023-05-05
Next Dividend Date
Company Information
ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, the company aims to disrupt the progression of cancer and offer its patients more good days.
CEO: Mark Enyedy
Website: www.immunogen.com
HQ: 84 State St Boston, 02109-2202 Massachusetts
Related News